SPECIALIZED PRESS January 23, 2020 Not intended for U.S. and UK MediaBayer receives approval for darolutamide in JapanRead more
January 21, 2020 Inclusion in the Bloomberg Gender-Equality IndexBayer a global leader in diversity and inclusionRead more
SPECIALIZED PRESS January 20, 2020 Not intended for U.S. and UK MediaBayer to showcase new data including research in immuno- and precision oncology at ASCO GI Cancers Symposium 2020Read more
January 20, 2020 CDP publishes new ranking:Bayer confirms leading international position as a sustainable company taking climate actionRead more
January 16, 2020 Bayer and WuXi Biologics enter into an agreement on a Leverkusen drug product plantRead more
January 13, 2020 Not intended for U.S. and UK MediaBayer and Daré Bioscience enter into exclusive license agreement for U.S. commercial rights to investigational hormone-free, monthly contraceptive Ovaprene®Read more
January 10, 2020 Bayer and Azitra partner to harness the human skin microbiome as a source for new natural skin care products for sensitive and eczema-prone skinRead more
January 9, 2020 Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discoveryRead more
January 9, 2020 Bayer and Evotec form new strategic alliance focusing on polycystic ovary syndromeRead more
January 7, 2020 Bayer exercises right to enter into follow-on research and collaboration option agreement with AtomwiseRead more
